drugset / Trial / NCT02965911
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this protocol is to conduct a trial in a selected population of patients with PBC based on an incomplete biochemical response after 12 months of UDCA therapy.
Timeline
- Start
- 2016-01
- Primary completion
- 2021-09-08
- Completion
- 2021-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenofibrate | Small molecule | 200 mg | Oral |
| Subject | Ursodeoxycholic Acid | Small molecule | 13 mg/kg | Oral |
| Subject | Ursodeoxycholic Acid | Small molecule | 15 mg/kg | Oral |